Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of Difficult-to-Treat Resistance in Gram-negative Bacteremia on Mortality: Retrospective Analysis of Nationwide Surveillance Data
Kyungmin Huh, Doo Ryeon Chung, Young Eun Ha, et al.
Clinical Infectious Diseases (2020) Vol. 71, Iss. 9, pp. e487-e496
Open Access | Times Cited: 77

Showing 26-50 of 77 citing articles:

Polymer-Carbon nanocomposite: Synthesis, optical and biocidal properties
Neethu Joseph, Aleena Ann Mathew, Elcey C. Daniel, et al.
Results in Chemistry (2023) Vol. 5, pp. 100826-100826
Open Access | Times Cited: 7
Antimicrobial Stewardship on Patients with Neutropenia: A Narrative Review Commissioned by Microorganisms
Joana Alves, Betânia Abreu, Pedro Palma, et al.
Microorganisms (2023) Vol. 11, Iss. 5, pp. 1127-1127
Open Access | Times Cited: 7
Prevalence of Colonization With Antibiotic-Resistant Organisms in Hospitalized and Community Individuals in Bangladesh, a Phenotypic Analysis: Findings From the Antibiotic Resistance in Communities and Hospitals (ARCH) Study
Fahmida Chowdhury, Syeda Mah‐E‐Muneer, Susan Bollinger, et al.
Clinical Infectious Diseases (2023) Vol. 77, Iss. Supplement_1, pp. S118-S124
Open Access | Times Cited: 7
Non-fermentative gram-negative bloodstream infection in northern Italy: a multicenter cohort study
Renato Pascale, Silvia Corcione, Linda Bussini, et al.
BMC Infectious Diseases (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 17
Prevalence of Antibiotic Resistance Over Time in a Third-Level University Hospital
Vincenzo Scaglione, M Reale, Chiara Davoli, et al.
Microbial Drug Resistance (2021) Vol. 28, Iss. 4, pp. 425-435
Open Access | Times Cited: 16
Variation in antibiotic resistance patterns for children and adults treated at 166 non-affiliated US facilities using EHR data
Shivani Sivasankar, Jennifer Goldman, Mark A. Hoffman
JAC-Antimicrobial Resistance (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 12
Carriage of Antibiotic Resistant Bacteria and Associated Factors Among Food Handlers in Tamale Metropolis, Ghana: Implications for Food Safety
Ezekiel Kofi Vicar, Desmond Baakibe Alo, Valentine Cheba Koyiri, et al.
Microbiology Insights (2023) Vol. 16
Open Access | Times Cited: 5
The Challenge of Bacteremia Treatment due to Non-Fermenting Gram-Negative Bacteria
Svetlana Sadyrbaeva-Dolgova, María Del Mar Sánchez Suárez, Juan Antonio Reguera, et al.
Microorganisms (2023) Vol. 11, Iss. 4, pp. 899-899
Open Access | Times Cited: 5
In vitro activity of ceftazidime-avibactam against clinical isolates of Enterobacterales and Pseudomonas aeruginosa from sub-Saharan Africa: ATLAS Global Surveillance Program 2017–2021
Mark G. Wise, James A. Karlowsky, Meredith Hackel, et al.
Journal of Global Antimicrobial Resistance (2023) Vol. 35, pp. 93-100
Open Access | Times Cited: 5
Moving towards a standardized definition of antimicrobial resistance: a comparison of the antimicrobial susceptibility profile of difficult-to-treat resistance (DTR) versus multidrug-resistant (MDR) Pseudomonas aeruginosa clinical isolates (CANWARD, 2016-2021)
Andrew Walkty, James A. Karlowsky, Philippe Lagacé‐Wiens, et al.
Diagnostic Microbiology and Infectious Disease (2023) Vol. 108, Iss. 2, pp. 116130-116130
Closed Access | Times Cited: 5
Activity of ceftolozane/tazobactam, imipenem/relebactam and ceftazidime/avibactam against clinical Gram-negative isolates—SMART United States 2019–21
James A. Karlowsky, Sibylle Lob, Karri A. Bauer, et al.
JAC-Antimicrobial Resistance (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 5
ESBL-positive Escherichia coli and Klebsiella pneumoniae isolates from across Canada: CANWARD surveillance study, 2007–18
James A. Karlowsky, Andrew Walkty, Alyssa Golden, et al.
Journal of Antimicrobial Chemotherapy (2021) Vol. 76, Iss. 11, pp. 2815-2824
Closed Access | Times Cited: 12
Clinical Outcomes, Microbiological Characteristics and Risk Factors for Difficult-to-Treat Resistance to Klebsiella pneumoniae Infection
Ping Yang, Chao Liu, Zhenchao Wu, et al.
Infection and Drug Resistance (2022) Vol. Volume 15, pp. 5959-5969
Open Access | Times Cited: 8
Incidence, risk factors and clinical outcome of multidrug-resistant organisms after heart transplantation
Sophia Hatzianastasiou, Paraskevas Vlachos, G Stravopodis, et al.
World Journal of Transplantation (2024) Vol. 14, Iss. 2
Closed Access | Times Cited: 1
Adult acute leukemia patients with gram-negative bacteria bloodstream infection: Risk factors and outcomes of antibiotic-resistant bacteria
Jinjin Wang, Mingchun Mu, Jinbing Zhu, et al.
Annals of Hematology (2024) Vol. 103, Iss. 10, pp. 4021-4031
Open Access | Times Cited: 1
Prevalence of difficult-to-treat resistance in ESKAPE pathogens in a third level hospital in Mexico
Adrián Camacho-Ortíz, Samantha Flores-Treviño, Paola Bocanegra‐Ibarias
Infection Prevention in Practice (2024) Vol. 7, Iss. 1, pp. 100426-100426
Open Access | Times Cited: 1
In vitro activity of ceftazidime/avibactam against clinical isolates of Enterobacterales and Pseudomonas aeruginosa from Middle Eastern and African countries: ATLAS global surveillance programme 2015–18
James A. Karlowsky, Samuel K. Bouchillon, Ramy El Mahdy Kotb, et al.
JAC-Antimicrobial Resistance (2021) Vol. 3, Iss. 2
Open Access | Times Cited: 11
In vitro activity of ceftazidime-avibactam against Gram-negative strains in Chile 2015–2021
Luis C. Torres-Castillo, Cecil Fandiño, María-Paz Ramos, et al.
Journal of Global Antimicrobial Resistance (2023) Vol. 35, pp. 143-148
Open Access | Times Cited: 4
Prevalence of Antimicrobial Resistance in Gram-Negative Bacteria Bloodstream Infections in Peru and Associated Outcomes: VIRAPERU Study
Fiorella Krapp, Coralith García, Noemí Hinostroza, et al.
American Journal of Tropical Medicine and Hygiene (2023) Vol. 109, Iss. 5, pp. 1095-1106
Open Access | Times Cited: 4
Plasma and Cerebrospinal Fluid Therapeutic Drug Monitoring of Ceftolozane and Tazobactam During Treatment of Multidrug-Resistant Pseudomonas aeruginosa Meningitis
Erin K McCreary, Karin Byers, Carolyn Fernandes, et al.
Open Forum Infectious Diseases (2020) Vol. 7, Iss. 12
Open Access | Times Cited: 11
Efficacy of teicoplanin in bloodstream infections caused by Enterococcus faecium: posthoc analysis of a nationwide surveillance
Soyoung Ha, Kyungmin Huh, Doo Ryeon Chung, et al.
International Journal of Infectious Diseases (2022) Vol. 122, pp. 506-513
Open Access | Times Cited: 7
Gram-negative Bacteria With Difficult-to-Treat Resistance: A Moving Target
Majdi N. Al‐Hasan
Clinical Infectious Diseases (2020) Vol. 72, Iss. 12, pp. 2121-2123
Open Access | Times Cited: 9
Trends in DTR, CR, ECR, and FQR in Four Common Gram-Negative Bacteria: A Retrospective Study from 2013 to 2021
Zhen Zhang, Lei Tian
Infection and Drug Resistance (2022) Vol. Volume 15, pp. 2625-2631
Open Access | Times Cited: 6
Difficult-to-treat resistant gram-negative blood stream infections – the beginning of a superbug era – a prospective observational study
Naveenraj Palanisamy, Deepak Kumar, Durga Shankar Meena, et al.
Indian Journal of Medical Microbiology (2023) Vol. 44, pp. 100364-100364
Open Access | Times Cited: 3
Global impact of antibacterial resistance in patients with hematologic malignancies and hematopoietic cell transplant recipients
Lee Gottesdiener, Michael J. Satlin
Transplant Infectious Disease (2023) Vol. 25, Iss. S1
Closed Access | Times Cited: 3

Scroll to top